Glucagon-like peptide-1 (GLP-1) is a well-known medication used by physicians to treat Type 2 diabetes. GLP-1 has also become ...

Just like ChatGPT and other generative language models train on human texts to create grammatically correct sentences, a new modeling method trains on recordings of birds to create accurate birdsongs.

An interdisciplinary research team from Leipzig University and the Saxon AI center ScaDS.AI has developed a novel approach ...

A team of microbiologists, chemists and pharmaceutical specialists at Shandong University, Guangzhou Medical University, ...

Weight-inclusive health care is the provision of equitable care without perpetuating weight stigma among patients of all body ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

The overgrown foliage had been hiding an ancient structure. Archaeologists identified the ruins as a pyramid-like building dating back at least 3,800 years, officials said. It has three ...

This serum utilizes a potent blend of exosomes, which Dr. Khalifian says contain growth factors, plus other helpful “biochemical cues” like peptides and lipids that signal to your skin cells ...

Department of Bioscience and Biomedical Engineering, Indian Institute of Technology-Bhilai, Durg, 491002, CG India Department of Chemistry, Indian Institute of Technology-Bhilai, Durg, 491002, CG ...

GLP-1, which stands for Glucagon-like peptide, is another fast-growing market. According to UBS estimates, the GLP-1 market is expected to grow ~30% CAGR from 2023-2029, reaching a market of $129 ...

Background: Despite their potential, Glucagon-like peptide-1 receptor agonists (GLP-1 RA) have not been well studied in cardiac amyloidosis (CA) as randomized trials on GLP-1 RA have excluded patients ...